We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Optibiotix Health Plc | LSE:OPTI | London | Ordinary Share | GB00BP0RTP38 | ORD 2P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 17.75 | 17.50 | 18.00 | 17.75 | 17.75 | 17.75 | 16,701 | 08:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Noncomml Resh Organizations | 457k | 2.59M | 0.0284 | 6.25 | 16.19M |
Date | Subject | Author | Discuss |
---|---|---|---|
10/5/2017 23:20 | More ramping elrico - sucking in more mugs. | monkeywench1 | |
10/5/2017 23:03 | Awe bless. Was someone doubting my position. Some companies just don't excite me as much, so I keep quiet, remain under the radar. PM with your email address, Monkey. I'll send you a copy of my trade. | elrico | |
10/5/2017 22:59 | Monky did you flag this as a ramp by elrico to? elrico - 02 Dec 2016 - 20:12:41 - 324 of 1185 Die Roboter - PRSM As of Nov 2016 PRSM had £11.8 million and supported by an inherent cash generative model. June 2016 cash at the period end of £11.2m including GBP8.8m from IPO proceeds (H1 2015: £1.1m). This suggests to me it can continue its sale and marketing initiative without burning much of of its cash reserves, in fact it may accelerate the net cash figure. £250 million market cap may be a little toppy now without further key revenue driving news - this may be just around the corner after Christmas. | pglancy | |
10/5/2017 22:57 | you wanna see my bank account :( Memo to self, don't buy any more OPTI shares! | whl2 | |
10/5/2017 22:53 | That's a terrible looking share price chart. | organstop | |
10/5/2017 22:52 | I've been invested here long enough to KNOW when the share is being played, it's the third time this pattern has emerged from memory, I didn't top up the last time and kicked myself for it as we sailed higher, I'm not going to miss the opportunity this time.Even if our mystery seller is not quite finished, so be it, I will move funds to add further. I'm have a target position in mind which I believe will be sufficient for early retirement, I'm not quite there yet so our seller could be a blessing in disguise. | trotterstrading | |
10/5/2017 22:50 | Here another ramp, just for you monekywench. I have you filtered but you are so predictable. Just had a poke from an a Stragen employer at Vitafood. OPTI/Nutrilliea stand was buzzing and there is talk of orders already. We will have to wait for OPTI to confirm this won't we. Obviously I cannot ask SOH to comment on this. Happy to wait for the RNS(s). | elrico | |
10/5/2017 22:36 | Please stop- you're posts are so ludicrous it's embarrassing! | f3rdinand | |
10/5/2017 22:24 | 60,000 dumped under the price at 59p | opodio | |
10/5/2017 22:23 | OMFG just had a thought. if the cash isnt raised there be a risk of accounts being qualified | opodio | |
10/5/2017 22:21 | Hang on a minute elrico. A few minutes ago you were bragging about your trading on the prsm board. Mmmm rather a lot of bs me thinks. | monkeywench1 | |
10/5/2017 22:18 | I thought it would stop at 70p. I keep telling myself I need to think like a trader, become more proficient in TA rather than just rely on fib ratios. The problem with this thinking is the danger of thinking like a trader and forgetting I'm an investor and investors don't usually concern themselves with trading ranges, instead, preferring to accumulate almost like a contrarian. Of course the other danger with this strategy....you risk falling in love xxx :)) Limit order at the ready...as JJ would say, sanguine-ish ;) | elrico | |
10/5/2017 21:45 | valuation too high loads of hot air and needs cash last placing was 8p thats how far it could fall | opodio | |
10/5/2017 21:19 | Parob - of course not! Sentiment back then was similar to what it is now. Problem on here is that people get too carried away when the share price rises and seem to forget the reasons they invested and the multiple opportunities here when the share price drops. Some loyal holders have sold out here giving away their qualification for their dividend in specie to skinbio after holding for a lengthy time. Not to mention the long awaited launch of one its prized assets in the form of lpldl in to multiple markets. This company continues to reach its publicly announced milestones yet the price has fallen... This seller has created a false decline due to low volume spooking the market and exaggerating the drop. The high volume day and the wave of blue at the end shows many were waiting for this to drop to low 60's and not jumping the gun before it hit. Fair play because that is an absolute great price, I thought it would stop st 65!. Hopefully the seller will now be clear following today's high volume. Few distribution announcements we'll be pushing 75+ in no time | riskybusiness1 | |
10/5/2017 21:05 | Sorry Speccy. Just wanted all to see. I have your blog bookmarked on my phone and suggest others do to! | parob | |
10/5/2017 20:57 | Speccy - I read it via the link, as usual. I did some liberating myself today. Sold my PRSM shares today. They have outperformed my expectation since late 2016 by doubling, just a tad more actually. Guess where the liberated funds are going. No, I won't tease, OPTI and SBTX. I am more overweight than you, Speccy. Shock horror! | elrico | |
10/5/2017 20:48 | Awww geez Parob - you're great and everything, but now everyone can read it on here - that's not going to get my reader count higher than the usual 3, and one of them's my Mum! My post was laced with intrigue about giant worms to entice hapless readers to my site Never mind - it got to 12 before you posted, so that's almost a record :) | speccy1 | |
10/5/2017 20:37 | and all your go up moneky. give yourself a pat on the head with a mallet as HARD AS YOU LIKE. | incanus | |
10/5/2017 20:33 | Speccy v good read. suspect your frustration will be rewarded if like me and many here have a long term view and dont concern yourself with trolls. they are so transparent arent they! | incanus | |
10/5/2017 20:23 | Nice blog Speech, John | 2350220 | |
10/5/2017 20:19 | This ramping is nonstop. I think a few folk are a few quid down. | monkeywench1 | |
10/5/2017 20:05 | I felt the need for an outpouring, but it's too long to post here (and I need a few visitors to my blog - pleeeease!) I will post the final sentence here though, as it sums up the sentiment of the rest of the blog post "I would have been feeling depressed and miserable after this week's price drops, but instead I feel elated and brimming with confidence that the worm will soon turn, and when it does it will be like one of them from Tremors and scoff everything in its path!" There's also a bit I want TW to read - if ShareProphets want to fight the establishment and help PIs then we need some serious lobbying to put an end to the arcane practice of needing to guess if a transaction is a buy or a sell - it's crazy we have to make investment decisions based on guesswork and is an open door for manipulation! Go OPTI - I love you ;) | speccy1 | |
10/5/2017 19:58 | Yesterday, a panel of experts at BioTrinity discussed the huge possibilities offered by the young microbiome field, which could soon overtake genetics. Scientists and investors worldwide are starting to turn to the microbiome, which many believe hold the key to human health. The microorganisms that live in us and on us have shown to play a role in conditions ranging from obesity to cancer and neurodegenerative disease. “I think it is a bigger deal than genetics,” says Tim Spector, CEO of Map my gut, a company that offers direct-to-consumer microbiome sequencing services. But he reckons that being such a new field, still driven by small companies, very few are collecting samples of the microbiome as they should.............. | maxwellsdemon |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions